Dr. Robert Evan Lozoff

D.D.S. | Dentist



  
  515 Sheridan Rd, 302, Evanston
  Illinois, 60202-4703

  720-317-8421    Maps & Directions
Dr. Robert Evan Lozoff is a Evanston, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 515 Sheridan Rd, 302, Evanston. Patients can reach him at 720-317-8421.
Dr. Robert Evan Lozoff is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Robert Evan Lozoff speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Robert Evan Lozoff
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:515 Sheridan Rd, 302, Evanston,
Illinois, 60202-4703
Phone:720-317-8421
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 1557656139
Enrollment ID: I20160822000719
NPI Number: 1881869279
NPI Enumeration Date: 25 Apr, 2008
NPI Last Update On: 19 Jul, 2016

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 515 Sheridan Rd, 302
Evanston, Illinois
Zip: 60202-4703
Phone Number: 720-317-8421
Patients can reach Dr. Robert Evan Lozoff at 515 Sheridan Rd, 302, Evanston, Illinois or can call to book an appointment on 720-317-8421. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: